4.3 Article

Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Stratum-specific positive predictive values of claims for acute pancreatitis among commercial health insurance plan enrollees with diabetes mellitus

David D. Dore et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)

Editorial Material Endocrinology & Metabolism

GLP-1-Based Therapy for Diabetes: What You Do Not Know Can Hurt You

Peter C. Butler et al.

DIABETES CARE (2010)

Article Endocrinology & Metabolism

Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin

Rajesh Garg et al.

DIABETES CARE (2010)

Article Endocrinology & Metabolism

Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes

C. J. Girman et al.

DIABETES OBESITY & METABOLISM (2010)

Editorial Material Endocrinology & Metabolism

Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

P. C. Butler et al.

DIABETOLOGIA (2010)

Article Endocrinology & Metabolism

Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas

J. S. Nachnani et al.

DIABETOLOGIA (2010)

Article Endocrinology & Metabolism

Pancreatic duct replication is increased with obesity and type 2 diabetes in humans

A. E. Butler et al.

DIABETOLOGIA (2010)

Review Medicine, General & Internal

Acute pancreatitis

Jean-Louis Frossard et al.

LANCET (2008)

Article Health Care Sciences & Services

The validity of Medicaid pharmacy claims for estimating drug use among elderly nursing home residents: The Oregon experience

DA McKenzie et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)

Article Pharmacology & Pharmacy

The risk of acute pancreatitis associated with acid-suppressing drugs

IA Eland et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)